Article
Exploring the Contribution of Interleukin-17 Genetic Polymorphisms to Pterygium Risk.
Anticancer research - 1 Mar 2026
Chen Hung-Chih, Hsia Ning-Yi, Hu Pei-Shin, Hsia Te-Chun, Yang Ya-Chen, Chang Wen-Shin, Chao Shih-Chun, Bau DA-Tian, Tsai Chia-Wen
Abstract excerpt
BACKGROUND/AIM: Pterygium is a chronic, fibrovascular ocular surface disorder with tumor-like biological behavior. Although inflammatory mediators such as interleukin-17 (IL17) are increasingly implicated in its pathogenesis, the genetic contribution of IL17 remain unclear. To our knowledge, this study is the first to investigate whether IL17A rs2275913 and IL17F rs763780 polymorphisms influence pterygium...
Topics
- Humans
- Interleukin-17
- Pterygium
- Male
- Female
- Genetic Predisposition to Disease
